HDL-C and weight changed together, not in interchangeable units
Gepner 2011, reported changes at one year after the target quit date. 334 visit abstainers and 589 continuing smokers. Parentheses are standard deviations (spread), not confidence intervals or expected personal ranges.
| Measured change | Visit abstainers | Continuing smokers |
|---|---|---|
| Mean HDL-C change | +2.4 (8.3) mg/dL | +0.1 (8.8) mg/dL |
| Mean weight change | +4.6 (5.7) kg | +0.7 (5.1) kg |
HDL-C is not LDL-C, particle count or an event
HDL-C measures cholesterol carried in high-density lipoproteins. It is distinct from LDL-C, triglycerides, total cholesterol and the number of HDL particles. The label ‘good cholesterol’ is shorthand, not a declaration that the whole lipid profile or cardiovascular risk is good. In this study, LDL-related changes were not statistically clear, and triglyceride findings were not clear after correction for multiple comparisons. This does not prove that those measures can never change.
A randomized treatment study, but not randomized successful quitting
The Wisconsin study recruited 1,504 motivated adult smokers in 2005–2007. Treatments were randomized; whether a participant successfully stopped was not. Only 923 returned at one year. The visit-abstinent group reported no smoking in the previous seven days, supported by exhaled carbon monoxide indicating recent exposure. That does not verify continuous abstinence throughout the year.
The comparison table keeps the simultaneous weight rise visible: a favourable average HDL-C change and weight gain can coexist. Models considered weight and several baseline factors, but later changes in alcohol use and activity were unavailable. About 39% missed the visit, the sample was mainly white, and there was no never-smoker control. The study cannot show that every quitter returned to a never-smoker level.
Why the pooled estimate is not a three-week target
A 2013 review identified 45 studies; its numerical analysis used 94 change estimates from 42 studies, not 94 independent trials. Its inverse-variance-weighted mean rise was 0.060 mmol/L (95% confidence interval 0.044–0.075), versus 0.107 (0.085–0.128) without weighting. Different study lengths and sizes affected these summaries, and missing variability often had to be estimated. Some quit times were inferred from interval midpoints. The review included the Wisconsin study, so it is not an independent replication of it. It also disclosed tobacco-company funding and tobacco-industry consulting relationships. These limitations rule out using the pooled averages as a personal improvement amount or deadline.
An unchanged result does not grade your quit attempt
The one-year analysis measured lipids, not subsequent heart attacks or strokes. It cannot convert a rise of a few mg/dL into your event-risk reduction. Conversely, an HDL-C value that does not rise cannot establish that stopping smoking was useless. Personal test interpretation and cardiovascular decisions require a qualified clinician considering the whole situation; this page sets no target, test schedule, diet, exercise or medicine plan.
For separate smoking support in England, NHS Better Health points to local Stop Smoking Services; elsewhere, ask your local health service about available help. A research average is not a condition you must meet before asking for support.
What to keep in mind
Sources
The central claims on this page were checked against the sources below.
- American Heart Journal: Gepner et al. (2011): lipid changes at a one-year smoking-cessation trial visit
Sources checked: 2026-10-08
- Biomarker Research: Forey et al. (2013): within-person HDL-C changes and study variation
Sources checked: 2026-10-08
- National Heart, Lung, and Blood Institute: Blood cholesterol: multiple causes and risk factors
Sources checked: 2026-10-08
- MedlinePlus / US National Library of Medicine: HDL and LDL: terminology and professional assessment
Sources checked: 2026-10-08
- NHS Better Health: Finding local Stop Smoking Service support in England
Sources checked: 2026-10-08
Group research education only, not interpretation of a lipid panel, a cardiovascular forecast or a testing and treatment plan.